GoodRx Holdings, Inc. (GDRX) stock
GDRXNasdaqServices-Computer Processing & Data PreparationFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 11/3037% below fair value
$3.47−0.04 (-1.14%)
Close on Nov 17, 2026Market cap $1.18BP/E 86.8Yield –
GoodRx enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
GoodRx's enterprise value was $1.45B on Nov 11, 2026, against $1.25B a year earlier. Over the last 5 years it ranged from $893.98M to $13.11B, with a median of $2.09B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.45B | +19.5% |
| 2025 | Dec 31, 2025 | $1.21B | -35.3% |
| 2024 | Dec 31, 2024 | $1.88B | -28.6% |
| 2023 | Dec 29, 2023 | $2.63B | +46.1% |
| 2022 | Dec 30, 2022 | $1.80B | -86.3% |
| 2021 | Dec 31, 2021 | $13.11B | +42.9% |
| 2020 | Dec 31, 2020 | $9.17B | – |
See a number that looks wrong?